Dr Anna Lavelle was appointed as Chair of the Medicines Australia Board in 2018, following on from roles as Deputy Chair and Independent Director. Dr Lavelle is an experienced Non-Executive Director, serving for nearly 30 years on the boards of not for profit, government and for profit entities including Chair Avatar Brokers, Cyban Pty Ltd, Hemideina Ltd and the Member Health Innovation Advisory Committee. From 2005 to 2016, she was the CEO of AusBiotech, the national industry association for the biotechnology, pharmaceutical and medical devices sectors. Dr Lavelle is an ATSE Fellow and has a PhD in Genetics.

Chair, Medicines Australia

Dr Anna Lavelle

Proudly sponsored by:

Session:

The Panel: State of the Industry

When:

Friday 20 March, 8:33am - 9:25am

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2022 SPONSORS

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

SPONSOR AND TRADE

(c) 2021 APP Conference 2022. All Rights Reserved.

LATEST NEWS

#APP2022

Events Division

The Pharmacy Guild of Australia

Queensland Branch

FOLLOW US

07 3831 9246

SITE CREDITS

CONTACT US

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:

APP Sand 1

AA8730

APP OCEAN 3

2F7A81

APP OCEAN 2

347D83

GOLD

D3A94A

TEAL 

4AB9B7